Results 61 to 70 of about 4,762 (102)

Computational structural studies of SGLT2-related polypharmacy. [PDF]

PLoS One
Lloyd A, Austin-Muttitt K, Mullins JGL.
europepmc   +1 more source

Sodium glucose co-transporter 2 inhibitors safety depending on their adverse drug reactions and glucose monitoring parameters in type 2 diabetes mellitus.

Indian J Pharmacol
Bellapu D, Darwin R.
europepmc   +1 more source

Metabolic consequences of perinatal bisphenol A and 17α-Ethinylestradiol exposure manifest in circadian alterations of energy homeostasis in adult male mice. [PDF]

Front Endocrinol (Lausanne)
Kalló I, Kádár A, Göblyös B, Vastagh C, Pap DM, Fekete C, Liposits Z.   +6 more
europepmc   +1 more source

A Validated RP-HPLC Method for Monitoring Pollutants Removal during Microalgae Bioremediation of Polluted Waters. [PDF]

Bull Environ Contam Toxicol
Santos B, Araújo J, Freitas F, Sobral AJFN, Encarnação T.   +4 more
europepmc   +1 more source

Metabolic Profiling of the EmDia Cohort by LC-MS Reveals Empagliflozin-Intake Associated Regulation of 1,5-anhydroglucitol and Urate. [PDF]

Proteomics
Schmitt F, Ten Cate V, Fischer Z, Hagen M, Steigenberger BA, Tenzer S, Wild PS, Schmidlin T.   +7 more
europepmc   +1 more source

Triple therapy of RAS inhibitors, dapagliflozin, and finerenone in diabetic kidney disease patients with nephrotic-range proteinuria: a real-world study. [PDF]

Sci Rep
Gu C, Li X, Guo X, Zhou J, Kang L, Fang M.   +5 more
europepmc   +1 more source

3D finite element analysis of removable partial denture with lingual bar major connector constructed with cobalt chromium, PEEK, PEKK, and BioHPP. [PDF]

BMC Oral Health
Zakaria Hashem Mostafa A, Sameh A, El Sayed El-Khamisy N.   +2 more
europepmc   +1 more source

Unraveling the Obesogenic Mechanism of Bisphenol A Through Network Toxicology and Molecular Docking: Identification of Key Molecular Targets. [PDF]

Int J Mol Sci
Zhang R, Zhao M, Wen H, Lin Z, Zhou X.
europepmc   +1 more source

Dapagliflozin for the Treatment of Collagenofibrotic Glomerulopathy. [PDF]

Intern Med
Imai E, Imai A, Izumi M, Nakazawa J, Fujii H, Nishi S.   +5 more
europepmc   +1 more source

Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. [PDF]

Adv Ther
Tangri N, Rastogi A, Sofue T.
europepmc   +1 more source